Ajoke Sobanjo-ter Meulen, MD, MSc, is the Vice President, Medical Affairs & Policy at Icosavax. In her role she leads the medical affairs strategy for Icosavax’s vaccine programs. Prior to joining Icosavax, Ajoke led the global maternal immunization initiative with a focus on Group B streptococcus vaccine development at the Bill & Melinda Gates Foundation. Previously, Ajoke led the Group B streptococcus maternal immunization clinical development program at Novartis Vaccines. Ajoke is board-certified in pediatric and adolescent medicine from the Julius-Maximilian University in Wuerzburg, Germany, completed a pediatric infectious diseases fellowship at Mount Sinai School of Medicine New York, and holds a MSc in Infectious Disease Epidemiology from the London School of Tropical Medicine and Hygiene, UK. Ajoke serves as an affiliate associate professor in Global Health at the University of Washington.
|
Join the Campaign against GBS Disease in babies! |
CONNECT TO GBSI |